Core Insights - The company Kefu Medical closed at 44.99 yuan on December 3, with a 3.62% increase, and a rolling PE ratio of 29.36, marking a new low in 16 days, with a total market capitalization of 9.398 billion yuan [1] - In the medical device industry, the average PE ratio is 51.40, with a median of 39.68, placing Kefu Medical at the 60th position in the industry ranking [1] - As of the Q3 2025 report, 10 institutions hold shares in Kefu Medical, with a total of 112.9708 million shares valued at 4.451 billion yuan [1] Company Overview - Kefu Medical Technology Co., Ltd. specializes in the research, production, sales, and service of medical devices, focusing on health monitoring, rehabilitation aids, medical care, respiratory support, and traditional Chinese medicine therapy [1] - The company has received several accolades, including the establishment of a national postdoctoral research station and recognition as a national intellectual property advantage enterprise and a national-level industrial design center [1] Financial Performance - For the Q3 2025 report, Kefu Medical achieved a revenue of 2.398 billion yuan, reflecting a year-on-year increase of 6.63%, and a net profit of 260 million yuan, up 3.30% year-on-year, with a gross profit margin of 53.35% [2] - The PE ratio (TTM) for Kefu Medical is 29.36, while the static PE is 30.15, and the price-to-book ratio is 1.99 [2]
可孚医疗收盘上涨3.62%，滚动市盈率29.36倍，总市值93.98亿元